SPHK2 and breast cancer: Specifically, S1P produced by overexpression of SK2 in the nucleus of breast cancer cells was shown to inhibit HDAC 1 and 2, thus increasing acetylation of H3 at K9, of H4 at K5, and rather weakly that of H2B at K12 [24].